Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
Add more filters










Database
Language
Publication year range
1.
J Invest Dermatol ; 126(8): 1869-78, 2006 Aug.
Article in English | MEDLINE | ID: mdl-16763547

ABSTRACT

Epidermal melanin reduces some effects of UV radiation, the major cause of skin cancer. To examine whether induced melanin can provide protection from sunburn injury, 65 subjects completed a trial with the potent synthetic melanotropin, [Nle4-D-Phe7]-alpha-melanocyte-stimulating hormone ([Nle4-D-Phe7]-alpha-MSH) delivered by subcutaneous injection into the abdomen at 0.16 mg/kg for three 10-day cycles over 3 months. Melanin density, measured by reflectance spectroscopy, increased significantly in all [Nle4-D-Phe7]-alpha-MSH-treated subjects. The highest increases were in volunteers with lowest baseline skin melanin levels. In subjects with low minimal erythemal dose (MED) skin type, melanin increased by an average of 41% (from 2.55 to 3.59, P < 0.0001 vs placebo) over eight separate skin sites compared with only 12% (from 4.18 to 4.70, P < 0.0001 vs placebo) in subjects with a high-MED skin type. Epidermal sunburn cells resulting from exposure to 3 MED of UV radiation were reduced by more than 50% after [Nle4-D-Phe7]-alpha-MSH treatment in the volunteers with low baseline MED. Thymine dimer formation was also shown to be reduced by 59% (P = 0.002) in the epidermal basal layer. This study has shown for the first time the potential ability of a synthetic hormone that augments melanin production to provide photoprotection to people who normally burn in direct sunlight.


Subject(s)
Skin Pigmentation/drug effects , Sunburn/prevention & control , Sunscreening Agents/administration & dosage , Ultraviolet Rays/adverse effects , alpha-MSH/analogs & derivatives , Adult , Anticarcinogenic Agents/administration & dosage , Biopsy , Epidermal Cells , Epidermis/drug effects , Epidermis/pathology , Female , Humans , Male , Melanins/metabolism , Melanocytes/drug effects , Melanocytes/metabolism , Melanocytes/pathology , Middle Aged , Pyrimidine Dimers/metabolism , Skin Pigmentation/radiation effects , Sunburn/drug therapy , Sunburn/pathology , White People , alpha-MSH/administration & dosage
2.
Australas J Dermatol ; 45(3): 184-5, 2004 Aug.
Article in English | MEDLINE | ID: mdl-15250900

ABSTRACT

A case of molluscum contagiosum arising on the face and neck of a woman using topical tacrolimus over a period of 6 weeks for the treatment of atopic dermatitis is presented. Of particular note, these lesions remained confined to areas treated with tacrolimus and did not extend to adjacent regions treated with topical corticosteroids.


Subject(s)
Dermatitis, Atopic/drug therapy , Immunosuppressive Agents/adverse effects , Molluscum Contagiosum/chemically induced , Tacrolimus/adverse effects , Administration, Topical , Adult , Betamethasone Valerate/administration & dosage , Female , Humans , Immunosuppressive Agents/administration & dosage , Molluscum Contagiosum/drug therapy , Ointments , Tacrolimus/administration & dosage , Treatment Outcome , Tretinoin/administration & dosage
3.
Australas J Dermatol ; 44(4): 267-9, 2003 Nov.
Article in English | MEDLINE | ID: mdl-14616493

ABSTRACT

A 45-year-old man presented with a rapidly enlarging tumour in an area of long-standing hypertrophic lichen planus of the lower leg. Histological examination of the resected specimen showed it to be a giant keratoacanthoma measuring 37 x 57 mm. Neoplastic change is a rarely reported complication of chronic variants of cutaneous lichen planus. To date there have been only two reports of keratoacanthoma development in association with lichen planus.


Subject(s)
Carcinoma, Squamous Cell/pathology , Cell Transformation, Neoplastic/pathology , Keratoacanthoma/pathology , Lichen Planus/pathology , Skin Neoplasms/pathology , Biopsy, Needle , Carcinoma, Squamous Cell/surgery , Follow-Up Studies , Humans , Hypertrophy/pathology , Immunohistochemistry , Male , Middle Aged , Risk Assessment , Severity of Illness Index , Skin Neoplasms/surgery , Treatment Outcome
4.
Australas J Dermatol ; 43(4): 305-8, 2002 Nov.
Article in English | MEDLINE | ID: mdl-12423441

ABSTRACT

Benign familial pemphigus (Hailey-Hailey disease) is a rare relapsing-remitting epidermal blistering disease palliated by a multitude of medical and surgical treatments. There are limited reports of benefit from low-penetration X-rays. We describe two resistant cases that appeared to respond initially to superficial radiotherapy, a 66-year-old man who had multiple courses to the groins (4 x 2.00 Gy/5 x 3.00 Gy) and to the axillae and low back (10 x 2.00 Gy) and a 53-year-old man treated twice to the groins and perineum (5 x 3.00 Gy/10 x 2.00 Gy). However, on longer follow up, benefit was found to be questionable. We conclude that while superficial radiotherapy may offer temporary relief, there is little evidence that it alters the natural history of this disease.


Subject(s)
Pemphigus, Benign Familial/radiotherapy , Aged , Humans , Male , Middle Aged , Pemphigus, Benign Familial/pathology , Radiotherapy Dosage
SELECTION OF CITATIONS
SEARCH DETAIL
...